Physiological Effects of Drugs Completed Phase 4 Trials for Risperidone (DB00734)

IndicationStatusPhase
DBCOND0033861 (Physiological Effects of Drugs)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00294008A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)